Sign In
Buy OCGN
$1.22
+0.0100 (+0.83%)
At Close: Jun 15, 2026
Better Short-Squeeze Stock: Clover Health or Ocugen?
05:55am, Friday, 02'nd Jul 2021
Both have the necessary ingredients for explosive short-squeeze returns.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ocugen, Inc. - OCGN
11:03pm, Thursday, 01'st Jul 2021
NEW YORK, July 1, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ: OCGN). Such investors are advised to contact
New York, New York--(Newsfile Corp. - July 1, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Ocu
Los Angeles, California--(Newsfile Corp. - July 1, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ocugen, Inc. ("Ocug
Sell Ocugen Stock Before the Other Shoe Finally Drops
04:27pm, Wednesday, 30'th Jun 2021
The bad news with Covaxin hasn't sunk in yet with OCGN stock investors, so get out while the stock still remains elevated. The post Sell Ocugen Stock Before the Other Shoe Finally Drops appeared first
Los Angeles, California--(Newsfile Corp. - June 30, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ocugen, Inc. ("Ocuge
What's Going On With Ocugen (OCGN) Stock Today?
05:01am, Wednesday, 30'th Jun 2021
Ocugen Inc (NASDAQ: OCGN) shares are trading 1.6% higher in the pre-market session on Wednesday amid high social media interest. The company's shares had closed nearly 2% lower at $8.46 in the regular
NEW YORK--(BUSINESS WIRE)-- #OCGN--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ocugen, Inc. (NASDAQ: OCGN) between February 2, 2021 and June 10, 202
New York, New York--(Newsfile Corp. - June 29, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Ocugen, Inc. (NASDAQ: OCGN) alleging that
If Ocugen Stock Is Worth $8, I'll Eat My Hat
11:38am, Tuesday, 29'th Jun 2021
The class-action lawsuits against Ocugen are getting prepared by lawyers. Trading at $8.35, OCGN stock looks ready to take a fall.
NEW YORK--(BUSINESS WIRE)--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ocugen, Inc. ("Ocugen" or "the Company") (NAS
Ocugen Stock Is A Bust After Covaxin's Emergency Use Rejection
10:57am, Tuesday, 29'th Jun 2021
OCGN stock is of no value to investors now that federal regulators closed the door on its Covid-19 vaccine commercialization efforts. The post Ocugen Stock Is A Bust After Covaxin's Emergency Use Reje
Is It Too Late to Buy Ocugen Stock?
10:52am, Tuesday, 29'th Jun 2021
The company has found a partner to manufacture its COVID-19 vaccine -- but will it be all for naught?
Los Angeles, California--(Newsfile Corp. - June 29, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ocugen, Inc. ("Ocuge
Get Rid of Ocugen Stock While You Can as the Bad News Piles Up
06:00am, Tuesday, 29'th Jun 2021
After OCGN stock rallied due to factors that were not based on fundamentals, investors should sell the shares. The post Get Rid of Ocugen Stock While You Can as the Bad News Piles Up appeared first on
